Published in Z Kardiol on January 01, 2005
Large femoral aneurysm as a late complication after vessel closure device application. Clin Res Cardiol (2006) 0.83
Temporary trans-coronary pacing by coated guidewires: a safe and reliable method during percutaneous coronary intervention. Clin Res Cardiol (2006) 0.78
Groin complications associated with collagen plug closure of femoral arterial puncture sites in anticoagulated patients. Cathet Cardiovasc Diagn (1998) 4.23
Postangiographic femoral artery injuries: nonsurgical repair with US-guided compression. Radiology (1991) 3.61
Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices. J Am Coll Cardiol (2001) 2.74
Role of superficial femoral artery puncture in the development of pseudoaneurysm and arteriovenous fistula complicating percutaneous transfemoral cardiac catheterization. Cathet Cardiovasc Diagn (1992) 1.82
Pseudoaneurysm after cardiac catheterization: therapeutic interventions and their sequelae: experience in 86 patients. Cathet Cardiovasc Diagn (1997) 1.62
Complications of femoral artery closure devices. Catheter Cardiovasc Interv (2001) 1.22
Use of vascular sealing devices (VasoSeal and Perclose) versus assisted manual compression (Femostop) in transcatheter coronary interventions requiring abciximab (ReoPro). Catheter Cardiovasc Interv (1999) 1.03
Iatrogenic vascular trauma. Semin Vasc Surg (1998) 1.00
Management of 219 consecutive cases of postcatheterization pseudoaneurysm. J Am Coll Cardiol (1997) 0.98
Vascular closure devices and the risk of vascular complications after percutaneous coronary intervention in patients receiving glycoprotein IIb-IIIa inhibitors. Am J Cardiol (2001) 0.97
Vascular injury following cardiac catheterization, coronary angiography, and coronary angioplasty. Eur Heart J (1994) 0.97
Femoral haemostasis after transcatheter therapeutic intervention: a prospective randomised study of the angio-seal device vs. the femostop device. Int J Cardiol (2001) 0.87
Suture closure of the femoral arteriotomy following invasive cardiac procedures: a detailed analysis of efficacy, complications, and the impact of early ambulation in 1,200 consecutive, unselected cases. Catheter Cardiovasc Interv (2001) 0.84
Efficacy and safety of a hemostatic puncture closure device with early ambulation after coronary angiography. Angio-Seal Investigators. Am J Cardiol (1998) 0.84
Clinical practice of primary angioplasty for the treatment of acute myocardial infarction in Germany: results from the MITRA and MIR registries. Z Kardiol (2002) 0.84
A randomised controlled trial of Prostar Plus for haemostasis in patients after coronary angioplasty. Eur J Vasc Endovasc Surg (2000) 0.83
[Use of heparin in acute myocardial infarction in routine clinical practice in Germany. Results of the MITRA and MIR registries]. Z Kardiol (2002) 0.80
A novel vascular sealing device for closure of percutaneous arterial access sites. Am J Cardiol (1999) 0.80
Do 5-F-catheters reduce the incidence of a pseudoaneurysm? Int Angiol (1996) 0.78
[Incidence and therapy of peripheral arterial vascular complications after heart catheter examinations]. Z Kardiol (1997) 0.78
[Local vascular complications after iatrogenic femoral artery puncture]. Wien Klin Wochenschr (1996) 0.78
[Local vascular complications in heart catheter studies]. Z Kardiol (1993) 0.78
[Minimally invasive percutaneous contrast-ultrasound guided thrombin occlusion of iatrogenic pseudoaneurysm]. Z Kardiol (2001) 0.77
A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med (2001) 6.53
Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography. N Engl J Med (1991) 3.26
Comparative genome organization of vertebrates. The First International Workshop on Comparative Genome Organization. Mamm Genome (1996) 2.97
AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011. Pharmacopsychiatry (2011) 2.91
Intravascular ultrasound and stent implantation: intraobserver and interobserver variability. Am Heart J (1999) 2.05
Functional analysis of separate topographies of aberrant behavior. J Appl Behav Anal (1994) 2.01
Unnatural ligands for engineered proteins: new tools for chemical genetics. Annu Rev Biophys Biomol Struct (2000) 1.99
Transesophageal echocardiography. N Engl J Med (1995) 1.91
Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries. Circ Res (1988) 1.77
Identification of patent foramen ovale permitting paradoxic embolism. J Am Coll Cardiol (1995) 1.71
Efficacy of an additional MAZE procedure using cooled-tip radiofrequency ablation in patients with chronic atrial fibrillation and mitral valve disease. A randomized, prospective trial. Eur Heart J (2002) 1.69
The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry. Pharmacopsychiatry (2004) 1.64
Angiotensin II-induced superoxide anion generation in human vascular endothelial cells: role of membrane-bound NADH-/NADPH-oxidases. Cardiovasc Res (1999) 1.55
Normal angiogram in acute coronary syndrome-preangiographic risk stratification, angiographic findings and follow-up. Int J Cardiol (2005) 1.50
The long-term effects of functional communication training in home settings. J Appl Behav Anal (1997) 1.47
Efficacy and safety of ticlopidine monotherapy versus ticlopidine and aspirin after coronary artery stenting: follow-up results of a randomized study. J Invasive Cardiol (2001) 1.43
Endothelial function in the forearm circulation of patients with the metabolic syndrome--effect of different lipid-lowering regimens. Cardiology (2005) 1.41
Diagnosis of patent foramen ovale by transesophageal echocardiography and association with cerebral and peripheral embolic events. Am J Cardiol (1992) 1.39
Colour Doppler ultrasound assessment of arteriovenous haemodialysis fistulas. Lancet (1992) 1.39
Autoimmunity to pancreatic juice in Crohn's disease. Results of an autoantibody screening in patients with chronic inflammatory bowel disease. Scand J Gastroenterol Suppl (1987) 1.37
The prehospital treatment of status epilepticus (PHTSE) study: design and methodology. Control Clin Trials (2001) 1.33
Engineered underdominance allows efficient and economical introgression of traits into pest populations. J Theor Biol (2001) 1.30
Nanoparticle technology for delivery of drugs across the blood-brain barrier. J Pharm Sci (1998) 1.27
Measurement of quality of life in pulmonary hypertension and its significance. Eur Respir J (2006) 1.23
Existence and functional role of alpha 1-adrenoceptors in the mammalian heart. J Mol Cell Cardiol (1985) 1.21
Obstructive sleep apnoea and its therapy influence high-density lipoprotein cholesterol serum levels. Eur Respir J (2006) 1.19
Detection of two novel porcine herpesviruses with high similarity to gammaherpesviruses. J Gen Virol (1999) 1.17
In vitro analyses of diamond-like carbon coated stents. Reduction of metal ion release, platelet activation, and thrombogenicity. Thromb Res (2000) 1.12
Decreased density of GABA-A receptors in the left sensorimotor cortex in akinetic catatonia: investigation of in vivo benzodiazepine receptor binding. J Neurol Neurosurg Psychiatry (1999) 1.12
Saline-irrigated, cooled-tip radiofrequency ablation is an effective technique to perform the maze procedure. Ann Thorac Surg (2001) 1.11
Prevalence, characteristics and clinical implications of regular atrial tachyarrhythmias in patients with atrial fibrillation: insights from a study using a new implantable device. J Am Coll Cardiol (2001) 1.11
Is impairment of ischaemic preconditioning by sulfonylurea drugs clinically important? Heart (2004) 1.09
Comparison of transthoracic and transesophageal echocardiography for detection of abnormalities of prosthetic and bioprosthetic valves in the mitral and aortic positions. Am J Cardiol (1993) 1.07
Crooked tail (Cd) models human folate-responsive neural tube defects. Hum Mol Genet (1999) 1.06
Pace-termination and pacing for prevention of atrial tachyarrhythmias: results from a multicenter study with an implantable device for atrial therapy. J Cardiovasc Electrophysiol (2001) 1.05
Dietary L-arginine reduces the progression of atherosclerosis in cholesterol-fed rabbits: comparison with lovastatin. Circulation (1997) 1.04
Lifetime risk of developing coronary heart disease. Lancet (1999) 1.04
Recurrent abdominal pain due to chronic appendiceal disease. South Med J (1991) 1.03
Role of increased production of superoxide anions by NAD(P)H oxidase and xanthine oxidase in prolonged endotoxemia. Hypertension (1999) 1.03
N(G)-nitro-L-arginine- and indomethacin-resistant endothelium-dependent relaxation in the rabbit renal artery: effect of hypercholesterolemia. Atherosclerosis (1997) 1.01
Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production. Atherosclerosis (1995) 1.01
Alpha-adrenoceptor-mediated positive inotropic effect of phenylephrine in isolated human ventricular myocardium. Eur J Pharmacol (1984) 1.00
Cardiotoxicity of 5-fluorouracil in combination with folinic acid in patients with gastrointestinal cancer. Cancer (1993) 0.99
[Autoantibodies against the exocrine pancreas and against intestinal goblet cells in the diagnosis of Crohn's disease and ulcerative colitis]. Dtsch Med Wochenschr (1984) 0.97
Endothelial-derived superoxide anions in pig coronary arteries: evidence from lucigenin chemiluminescence and histochemical techniques. J Physiol (1997) 0.97
Influence of the pacing rate on the atrioventricular conduction time during aerobic and anaerobic exercise: basic concepts for a dromotropically controlled rate responsive pacemaker. Pacing Clin Electrophysiol (1999) 0.96
Endothelium-dependent relaxation of human epicardial coronary arteries: frequent lack of effect of acetylcholine. Eur J Pharmacol (1986) 0.94
Gender differences in the generation of superoxide anions in the rat aorta. Life Sci (1997) 0.93
Anti-MPO-ANCA-positive microscopic polyangiitis following subacute bacterial endocarditis. Clin Rheumatol (2001) 0.92
[Aortic stenosis]. Clin Res Cardiol (2006) 0.92
Prehension with the ipsilesional hand after unilateral brain damage. Cortex (1999) 0.92
Response of human coronary arteries to aggregating platelets: importance of endothelium-derived relaxing factor and prostanoids. Circ Res (1988) 0.91
Unique properties of R-type calcium currents in neocortical and neostriatal neurons. J Neurophysiol (2000) 0.91
Monoclonal antibody-defined human pancreatic cancer-associated antigens. Cancer Res (1985) 0.90
Papillary fibroelastoma of the aortic valve presenting with myocardial infarction. Ann Thorac Surg (1995) 0.89
Recurrent angina pectoris in patients with internal mammary artery to coronary artery bypass: treatment with coil embolization of unligated side branches. Radiology (1996) 0.88
Effects of the beta 2-adrenoceptor agonists fenoterol and salbutamol on force of contraction in isolated human ventricular myocardium. Klin Wochenschr (1985) 0.88
Functional evidence for the existence of adenosine receptors in the human heart. Eur J Pharmacol (1985) 0.88
Myocardial alpha-adrenoceptors and positive inotropy. J Mol Cell Cardiol (1986) 0.88
Safety of high-intensity treatment with the irreversible monoamine oxidase inhibitor tranylcypromine in patients with treatment-resistant depression. Pharmacopsychiatry (2008) 0.87
Free radicals from plastic syringes. Free Radic Biol Med (1991) 0.87
Multi-anode detection in electrospray ionization time-of-flight mass spectrometry. J Am Soc Mass Spectrom (1998) 0.87
Dosimetric integration of daily mega-voltage cone-beam CT for image-guided intensity-modulated radiotherapy. Strahlenther Onkol (2012) 0.86
Multiplane transoesophageal echocardiography detection of a papillary fibroelastoma of the aortic valve causing myocardial infarction. Eur Heart J (1995) 0.86
Dietary L-arginine and alpha-tocopherol reduce vascular oxidative stress and preserve endothelial function in hypercholesterolemic rabbits via different mechanisms. Atherosclerosis (1998) 0.86
Surface plasmon polariton absorption modulator. Opt Express (2011) 0.86
Value of transesophageal color Doppler echocardiography for detection of different types of atrial septal defect in adults. J Am Soc Echocardiogr (1992) 0.86
5-Lipoxygenase inhibitors induce potent anti-proliferative and cytotoxic effects in human tumour cells independently of suppression of 5-lipoxygenase activity. Br J Pharmacol (2010) 0.85
Segmentation of 3D intravascular ultrasonic images based on a random field model. Ultrasound Med Biol (2000) 0.85
Vascular responses to platelet activation in normal and atherosclerotic primates in vivo. Arterioscler Thromb (1991) 0.84
Increased myocardial alpha 1 adrenoceptor density in rats chronically treated with propranolol. Eur J Pharmacol (1985) 0.84
[Intratumoral Onyx embolisation in the management of juvenile nasopharyngeal angiofibroma]. HNO (2010) 0.84
Harris lines of the tibia across centuries: a comparison of two populations, medieval and contemporary in Central Europe. Skeletal Radiol (2004) 0.84
CD31+/Annexin V+ microparticles in healthy offsprings of patients with coronary artery disease. Eur J Clin Invest (2009) 0.83
Conservative management of a brain abscess in a patient with Staphylococcus lugdunensis endocarditis. Eur J Clin Microbiol Infect Dis (2006) 0.83
A cohort study of employees of a manufacturing plant using trichlorethylene. J Occup Med (1985) 0.83
Tricuspid valve regurgitation attributable to endomyocardial biopsies and rejection in heart transplantation. Ann Thorac Surg (1995) 0.83
L-arginine supplementation in hypercholesterolemic rabbits normalizes leukocyte adhesion to non-endothelial matrix. Life Sci (2000) 0.83
Atrial pacing in the prevention of paroxysmal atrial fibrillation: first results of a new combined algorithm. Pacing Clin Electrophysiol (2000) 0.82
Substrate-modification using electroanatomical mapping in sinus rhythm to treat ventricular tachycardia in patients with ischemic cardiomyopathy. Z Kardiol (2005) 0.82
[Health promotion and cardiovascular risk factors. The level of knowledge among 510 inpatients of an acute coronary care unit]. Med Klin (Munich) (2000) 0.82
[In-hospital resuscitation. Concept of first-responder resuscitation using semi-automated external defibrillators (AED)]. Dtsch Med Wochenschr (2006) 0.82
Myocardial fractional flow reserve. Its role in guiding PCI in stable coronary artery disease. Herz (2011) 0.81
17Beta-estradiol acutely improves endothelium-dependent relaxation to bradykinin in isolated human coronary arteries. Eur J Pharmacol (1998) 0.81
Beta-blockers reduce the release and synthesis of endothelin-1 in human endothelial cells. Eur J Clin Invest (1999) 0.81
Comparative studies of the respiratory function of mammalian blood. V. Insectivora: shrew, mole and nonhibernating and hibernating hedgehog. Respir Physiol (1969) 0.80
Thienopyridines and statins: assessing a potential drug-drug interaction. Curr Pharm Des (2006) 0.80
Imaging of coronary arteries by color-coded transesophageal Doppler echocardiography. Am J Cardiol (1988) 0.80
Rapid engraftment of human ALL in NOD/SCID mice involves deficient apoptosis signaling. Cell Death Dis (2012) 0.80
Risk of bacteremia induced by transesophageal echocardiography: analysis of 100 consecutive procedures. J Am Soc Echocardiogr (1992) 0.80